Announcement • Jul 15
Borealis Foods Launches Chef Woo High-Protein Noodles At Costco Borealis Foods Inc. announced the launch of Chef Woo High-Protein Noodles at Costco. The launch has already generated strong early member demand. Industry research indicates that increased use of GLP-1 medications, including semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), and liraglutide (Saxenda®), for weight loss, have significantly influenced eating habits, with many consumers placing greater emphasis on protein-rich, nutrient-dense foods. Chef Woo is well positioned for this evolving marketplace, combining 20 grams of high quality complete protein with all 9 essential amino acids per serving. Chef Woo High-Protein Noodles featured on Costco social amid growing demand for convenient, protein-rich foods among consumers focused on weight management and nutrition. Each serving provides 20 grams of complete protein with all nine essential amino acids. Announcement • Jul 09
Borealis Foods Inc. Receives Notice of Non-Compliance with Nasdaq Listing Rule On July 2, 2026, Borealis Foods Inc. (the Company) received a notice (the Notice) from The Nasdaq Stock Market LLC (Nasdaq) indicating that, based on the Company's Market Value of Listed Securities (MVLS) for the last 30 consecutive business days, the Company no longer satisfies the minimum MVLS requirement of $35,000,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the MVLS Rule). The Notice also states that the Company does not currently satisfy the alternative continued listing standards under Nasdaq Listing Rules 5550(b)(1) (stockholders' equity) and 5550(b)(3) (net income from continuing operations). The Notice has no immediate effect on the listing or trading of the Company's Common Shares on The Nasdaq Capital Market. The Notice pertains to the Company's Common Shares; the continued listing of the Company's Warrants is dependent on the continued listing of the Common Shares, and if the Common Shares were to be delisted from The Nasdaq Capital Market, the Warrants would also cease to be listed. This Current Report on Form 8-K constitutes the Company's public announcement of receipt of the Notice, as required by Nasdaq Listing Rule 5810(b). Nasdaq Listing Rule 5810(c)(3)(C) provides the Company a compliance period of 180 calendar days, or until December 29, 2026, in which to regain compliance with the MVLS Rule. The Company will regain compliance if, at any time during the compliance period, the Company's MVLS closes at $35,000,000 or more for a minimum of ten consecutive business days, although Nasdaq staff has discretion to require the Company to maintain a closing MVLS of $35,000,000 or more for up to 20 consecutive business days before determining that the Company has demonstrated an ability to maintain long-term compliance. If the Company does not regain compliance with the MVLS Rule prior to the expiration of the compliance period, the Company will receive written notification from Nasdaq that its securities are subject to delisting, at which time the Company would be entitled to appeal Nasdaq's delisting determination to a Hearings Panel. The Company intends to monitor the market value of its listed securities during the compliance period and to consider available options for regaining compliance with the MVLS Rule. There can be no assurance that the Company will be able to regain or maintain compliance with the MVLS Rule or any other Nasdaq continued listing requirement. Announcement • May 28
Borealis Foods Inc. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q for Fiscal Quarter Ended March 31, 2026 Borealis Foods Inc. announced that on May 21, 2026, the Company received a notice from The Nasdaq Stock Market LLC indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 with the Securities and Exchange Commission. The Notice supplements the prior notice received by the Company from Nasdaq on April 17, 2026 relating to the Company's delayed Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as previously disclosed. The Notice has no immediate effect on the listing or trading of the Company's Common Shares or Warrants on the Nasdaq Capital Market. In accordance with Nasdaq's listing rules, the Company has until June 16, 2026 to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with the Listing Rule with respect to both the 2025 Form 10-K and Q12026 Form 10-Q. If Nasdaq accepts the Company's plan, Nasdaq may grant the Company up to 180 calendar days from the due date of the 2025 Form 10-K, or until October 12, 2026, to regain compliance. The Company intends to file the first quarter 2026 Form 10-Q as soon as practicable, and currently expects to do so no later than early June 2026, which the Company believes, together with the filing of the 2025 Form 10-K, will cure the deficiency and regain compliance with the Listing Rule. 
